Deutsche Bank’s Codiak BioSciences, Inc. Common Stock CDAK Stock Holding History

Deutsche Bank’s Portfolio CDAK Stock Details CDAK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-9,550	Closed	-$60K	–	4417
2022 Q1	$60K	Sell	9,550 -1,018	-10%	-$6.39K	﹤0.01%	3781
2021 Q4	$118K	Buy	10,568 +502	+5%	+$6.96K	﹤0.01%	3638
2021 Q3	$164K	Sell	10,066 -171	-2%	-$3.06K	﹤0.01%	3672
2021 Q2	$190K	Buy	10,237 +6,689	+189%	+$128K	﹤0.01%	3816
2021 Q1	$54K	Sell	3,548 -348	-9%	-$7.57K	﹤0.01%	4222
2020 Q4	$126K	Buy	+3,896	New	+$51.5K	﹤0.01%	3723

Other funds holding CDAK

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

UOTTAIMCU

University of Texas/Texas AM Investment Management Co (UTIMCO) Austin, Texas $687M AUM 21.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Ensign Peak Advisors Salt Lake City, Utah $53.7B AUM 29.47% 1-Year Est. Return

OIM

Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

LCM

Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return

Deutsche Bank's CDAK Position: Q2 2022 in Review

Deutsche Bank sold out of Codiak BioSciences, Inc. Common Stock (CDAK) in Q2 2022, closing a stake of 9,550 shares — an estimated $60K sold.

Deutsche Bank first reported a position in CDAK in Q4 2020 and held it in 6 quarters. The position peaked at $190K in Q2 2021. 49 funds tracked by Wall St. Rank hold CDAK as of Q2 2022.

Deutsche Bank reported no remaining Codiak BioSciences, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
Deutsche Bank sold 9,550 Codiak BioSciences, Inc. Common Stock shares in Q2 2022, an estimated $60K.
Deutsche Bank first reported a position in Codiak BioSciences, Inc. Common Stock in Q4 2020 and held it in 6 quarters.
Deutsche Bank's Codiak BioSciences, Inc. Common Stock position peaked at $190K in Q2 2021.
49 funds tracked by Wall St. Rank held Codiak BioSciences, Inc. Common Stock as of Q2 2022.

Based on Deutsche Bank's 13F filing for Q2 2022, filed 11 Aug 2022.